BioSpace News Archive

Press Releases

D3 Bio Announces Nature Medicine Publication and AACR 2025 Presentation Highlighting D3S-001 as a Next-Generation KRAS G12C Inhibitor with Best-in-Class Potential

April 29, 2025
·
4 min read
Press Releases

Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST

April 29, 2025
·
8 min read
Press Releases

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

April 29, 2025
·
5 min read
Press Releases

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

April 29, 2025
·
3 min read
Press Releases

Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting

April 29, 2025
·
6 min read
Press Releases

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

April 29, 2025
·
1 min read
Press Releases

Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting

April 29, 2025
·
2 min read
Press Releases

Ventus Therapeutics to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference

April 29, 2025
·
1 min read
Press Releases

Aulos Bioscience Presents New Phase 2 Data for AU-007 Demonstrating Continued Strong Anti-Tumor Activity in Advanced Cancers at AACR Annual Meeting

April 29, 2025
·
8 min read
Press Releases

Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

April 29, 2025
·
5 min read